Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation

OBJECTIVE: Prevention of recurrent stroke in patients with embolic stroke of undetermined source (ESUS) is challenging. The advent of safer anticoagulation in the form of direct oral anticoagulants (DOACs) has prompted exploration of prophylactic anticoagulation for all ESUS patients, rather than an...

Descripción completa

Detalles Bibliográficos
Autores principales: Witte, Klaus K., Tsivgoulis, Georgios, Reynolds, Matthew R., Tsintzos, Stelios I., Eggington, Simon, Ismyrloglou, Eleni, Lyon, Julie, Huynh, Marianne, Egea, Marta, de Brouwer, Bonnie, Ziegler, Paul D., Franco, Noreli, Joglekar, Rashmi, Rosemas, Sarah C., Liu, Shufeng, Thijs, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015049/
https://www.ncbi.nlm.nih.gov/pubmed/33789592
http://dx.doi.org/10.1186/s12872-021-01967-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015049/
https://www.ncbi.nlm.nih.gov/pubmed/33789592
http://dx.doi.org/10.1186/s12872-021-01967-x

Ejemplares similares